← 返回

用于分级免疫效应细胞相关血液毒性的自动化计算方法的开发与验证

英文原题:Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.

查看英文原题

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.

PubMed 2024/04/16(内容时间) Bone Marrow Transplant Q1 · IF 5.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

血液学毒性常使嵌合抗原受体(CAR)T细胞治疗复杂化,导致显著发病和死亡。为统一报告标准,欧洲血液学会(EHA)和欧洲血液与骨髓移植学会(EBMT)制定了免疫效应细胞相关血液毒性(ICAHT)分级系统,根据中性粒细胞减少的程度和持续时间,将事件分为早期(第0–30天)和晚期(第30天后)。但手动实施ICAHT分级标准耗时,且容易受主观判断和错误影响。为解决这些问题,我们开发了一种基于R语言的计算方法,自动完成早期和晚期ICAHT分级。鉴于早期ICAHT分级较复杂,我们在两个独立队列中对该方法进行人工和计算评估,队列合计1,251例患者。该计算方法有望简化分级流程,减少人工时间和精力,并促进不同临床环境中的标准化。我们向科学界提供该工具及全面的实施指南,以推动广泛应用并提高ICAHT报告一致性。

展开英文摘要原文

Hematologic toxicity frequently complicates chimeric antigen receptor (CAR) T-cell therapy, resulting in significant morbidity and mortality. In an effort to standardize reporting, the European Hematology Association (EHA) and European Society of Blood and Marrow Transplantation (EBMT) devised the immune effector cell-associated hematotoxicity (ICAHT) grading system, distinguishing between early (day 0-30) and late (after day +30) events based on neutropenia depth and duration.

However, manual implementation of ICAHT grading criteria is time-consuming and susceptible to subjectivity and error. To address these challenges, we introduce a novel computational approach, utilizing the R programming language, to automate early and late ICAHT grading. Given the complexities of early ICAHT grading, we benchmarked our approach both manually and computationally in two independent cohorts totaling 1251 patients.

Our computational approach offers significant implications by streamlining grading processes, reducing manual time and effort, and promoting standardization across varied clinical settings.

We provide this tool to the scientific community alongside a comprehensive implementation guide, fostering its widespread adoption and enhancing reporting consistency for ICAHT.

论文信息

作者
Liang EC、Rejeski K、Fei T、Albittar A、Huang JJ、Portuguese AJ、Wu Q、Raj S
单位
Fred Hutchinson Cancer Center, Seattle, WA, USA. ecliang@uw.edu.United States
文献类型
验证性研究
期刊
Bone marrow transplantation2024 Jul
原文标识
PubMed 38627450 · DOI 10.1038/s41409-024-02278-3